ImportRefusal LogoImportRefusal

Redrose Manufacturing Ltd

⚠️ Moderate Risk

FEI: 3005280521 • Houghton Le Spring, SND • UNITED KINGDOM

FEI

FEI Number

3005280521

📍

Location

Houghton Le Spring, SND

🇬🇧
🏢

Address

Unit 21A/B, Cherry Way, Houghton Le Spring, SND, United Kingdom

Moderate Risk

FDA Import Risk Assessment

32.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
7
Unique Violations
11/8/2013
Latest Refusal
4/6/2011
Earliest Refusal

Score Breakdown

Violation Severity
49.1×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
27.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3332×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

4822×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

Refusal History

DateProductViolationsDivision
11/8/2013
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
3/27/2013
54FBT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
482NUTRIT LBL
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/27/2012
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
333LACKS FIRM
Cincinnati District Office (CIN-DO)
11/27/2012
66VPJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
333LACKS FIRM
Cincinnati District Office (CIN-DO)
11/1/2011
54YCE99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
324NO ENGLISH
Los Angeles District Office (LOS-DO)
9/29/2011
61RBE11ACTIVATED CHARCOAL (ANTIDOTE)
16DIRECTIONS
New York District Office (NYK-DO)
4/6/2011
54YNY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
482NUTRIT LBL
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Redrose Manufacturing Ltd's FDA import refusal history?

Redrose Manufacturing Ltd (FEI: 3005280521) has 7 FDA import refusal record(s) in our database, spanning from 4/6/2011 to 11/8/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Redrose Manufacturing Ltd's FEI number is 3005280521.

What types of violations has Redrose Manufacturing Ltd received?

Redrose Manufacturing Ltd has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Redrose Manufacturing Ltd come from?

All FDA import refusal data for Redrose Manufacturing Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.